Evidence map›Paper›PMID 36046526›Full record

ArticleHeliyon2022

Identification of two novel thiazolidin-2-imines as tyrosinase inhibitors: synthesis, crystal structure, molecular docking and DFT studies.

Syeda Aaliya Shehzadi, Aamer Saeed, Fouzia Perveen, Pervaiz Ali Channar, Ifzan Arshad, Qamar Abbas, Saima Kalsoom, Sammer Yousaf, Jim Simpson

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Copper-Catalyzed One-Pot Synthesis of Thiazolidin-2-imines.The Journal of organic chemistry · 2024
    Article
  3. Molecules (Basel, Switzerland) · 2024
    Article
  4. Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 2 countries.

Syeda Aaliya ShehzadiSulaiman Bin Abdullah Aba Al-Khail-Centre for Interdisciplinary Research in Basic Sciences (SA-CIRBS), International Islamic University, 44000 Islamabad, Pakistan.
Aamer SaeedDepartment of Chemistry, Quaid-i-Azam University, 45320 Islamabad, Pakistan.
Fouzia PerveenResearch Center for Modelling and Simulations (RCMS), National University of Sciences and Technology (NUST), H-12 Islamabad, Pakistan.
Pervaiz Ali ChannarDepartment of Chemistry, Quaid-i-Azam University, 45320 Islamabad, Pakistan.
Ifzan ArshadDepartment of Chemistry, University of Management and Technology, Sialkot, Pakistan.
Qamar AbbasDepartment of Physiology, University of Sindh, Jamshoro, Pakistan.
Saima KalsoomDepartment of Chemistry, Preston University, Islamabad, Pakistan.
Sammer YousafH.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, 75270, Karachi, Pakistan.
Jim SimpsonDepartment of Chemistry, University of Otago, PO Box 56, Dunedin, New Zealand.
Quaid-i-Azam University · PKInternational Islamic University, Islamabad · PKNational University of Sciences and Technology · PKPreston University · PKUniversity of Karachi · PKUniversity of Management and Technology · PKUniversity of Otago · NZUniversity of Sindh · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various

Indexed as

Crystal structuresDFT studiesMolecular dockingN,S-heterocyclesThiazolidine-2-iminesTyrosinase inhibitors

Identifiers

PMID36046526
PMCPMC9421195
OpenAlexW4290999111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.